Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai East Hospital

About this trial

FAP-targeted PET imaging using 68Ga-FAPI enables early detection of myocardial fibrosis. Combined PET/CMR provides comprehensive cardiac assessment without extra radiation. This advanced imaging approach improves diagnosis and personalized treatment for better patient outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants must have a confirmed clinical diagnosis of cardiovascular disease by a cardiologist, based on genetic testing, family history, and comprehensive clinical evaluation including physical examination, echocardiography, and when indicated, cardiac MRI findings.

Age requirement: >18 years.

Patients should demonstrate stable cardiovascular status without significant changes in symptoms, treatment, or clinical findings for a specified pre-enrollment period.

Participants must be capable of providing informed consent and willing to adhere to all study requirements, including follow-up procedures.

Disqualifiers

History of malignancy

Documented cardiovascular diseases, including coronary artery disease, myocardial infarction, or related conditions

Implanted metallic devices (e.g., pacemakers, aneurysm clips) or other MRI-incompatible medical prostheses

Claustrophobia

Trial population

Patients with cardiovascular diseases

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

40 Participants
are grouped into 2 trial groups
Group A: Research group
Group B: Healthy controls

Trial outcomes

Primary outcomes

1

CE-CMR

Left ventricular wall thickness was quantified on short-axis cine images using the MR cardiac analysis software .

Time frame
After the patient completes the scan, an average of 2 days.
2

CE-MRI

Left ventricular ejection fraction (LVEF) was calculated from short-axis cine images using the cardiac MR analysis software.

Time frame
After the patient completes the scan, an average of 2 days.
3

PET

The maximum standardized uptake value (SUVmax) was calculated for each myocardial segment.

Time frame
After the patient completes the scan, an average of 2 days.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.